Eliminating Hepatitis C Transmission By Enhancing Hepatitis C Care And Treatment In Primary Health Care Settings.
Funder
National Health and Medical Research Council
Funding Amount
$1,221,831.00
Summary
In developed countries, people who inject drugs (PWID) are the group at greatest risk of hepatitis C (HCV) infection but few PWID receive HCV treatment. With the advent of highly effective non-interferon based treatments HCV elimination, although ambitious, is now being seriously considered globally. This partnership grant will explore the feasibility of eliminating HCV transmission by enhancing HCV care and treatment for PWID in primary health care settings.
Surveillance And Treatment Of Prisoners With Hepatitis C (SToP-C)
Funder
National Health and Medical Research Council
Funding Amount
$1,560,494.00
Summary
SToP-C will investigate whether a significant reduction in hepatitis C infection in NSW prisons is possible with a “treatment as prevention” strategy. It will treat prisoners for hep C infection both to improve their own health and to make onward transmission to others less likely. There is currently a lack of available effective strategies; however through delivery of simple, effective new therapies this world-first trial offers significant opportunities to reduce the burden of liver disease.
Enhancing Treatment Of Hepatitis C In Opioid Substitution Settings II (ETHOS II): A Partnership Project To Enhance Hepatitis C Care In Drug And Alcohol Clinics
Funder
National Health and Medical Research Council
Funding Amount
$1,265,716.00
Summary
This Partnership Project will evaluate novel strategies to enhance care for hepatitis C infection in drug and alcohol clinics. Based on a foundation of strong, existing partnerships, this project has considerable potential to facilitate the translation of research outcomes into policy and practice and facilitate the scale-up of hepatitis C care in drug and alcohol clinics in NSW and nationally.
Prevention And Treatment Of Viral Hepatitis Amongst Prisoners
Funder
National Health and Medical Research Council
Funding Amount
$1,102,510.00
Summary
Hepatitis B and C infection rates remain very high in some Australian populations, notably prisoners. As this group cycles frequently back to the general community, prevention of transmission is critical. Antiviral treatment uptake remains very low in Australia, yet the prison environment offers a unique opportunity to address this. This project aims to assess effectiveness of existing prevention strategies, guide new control measures, and to evaluate a novel nurse-led model for treatment.